You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion supports the World Federation Of Hemophilia Virtual Summit 2020

The company reaffirms its commitment to the patient community during the COVID-19 epidemic

read more 

CORPORATE

Kedrion-Kamada collaboration, first batch of Covid-19 IG released in Israel

The two companies are now working to expand the Clinical Development Program to the US

read more 

EVENTS

Kedrion Biopharma supports the 2020 Primary Immunodeficiency Week

The company stands alongside the global PI community

read more 
  1. CORPORATE - 05-11-2018

    First Annual International Symposium for the Global Eradication of Rh Disease ends a year of celebrations

    The event, supported by Kedrion among others, was held on November 1st at Columbia University in NY

    read more 
  2. EVENTS - 26-10-2018

    Kedrion renews its commitment to PID patients at ESID 2018

    18th edition of the Biennial Meeting of the European Society for Immunodeficiencies helds in Lisbon (Oct. 24 to 27)

    read more 
  3. EVENTS - 22-10-2018

    50 years of Anti-D celebrated at World Congress of Gynecology and Obstetrics in Rio De Janeiro

    Kedrion supports educational symposium to help Rh disease awareness and eradication

    read more 
  4. EVENTS - 18-10-2018

    EIGHT, the global educational initiative on Hemophilia A and its treatment

    Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October

    read more 

Pages

For more information please contact: pressoffice@kedrion.com